Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts

European Respiratory Journal

Volumn 15, Issue 1, 2000, Pages 68-74

  Spoelstra, F M ^a   Postma, D S ^a   Hovenga, H ^a   Noordhoek, J A ^a   Kauffman, H F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adhesion molecules; Budesonide; Formoterol; Lung fibroblasts

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; FORMOTEROL; GAMMA INTERFERON; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATING ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION;

ADRENERGIC BETA-AGONISTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; FIBROBLASTS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUNG; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033973128     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15a13.x     Document Type: Article

References (42)

1. Gauvreau GM, Doctor J, Watson RM, Jordana M, O'Byrne PM. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996; 154: 1267-1271.
2. Oddera S, Silvestri M, Sacco O, Lantero S, Morelli MC, Rossi GA. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Ann Allergy Asthma Immunol 1995; 75: 33-40.
3. Linden M, Brattsand R. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1β, and IL-6. Pulm Pharmacol 1994; 7: 43-47.
4. Miyamasu M, Misaki Y, Izumi S, et al. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol 1998; 101: 75-83.
5. Mullol J, Xaubet A, Lopez E, Roca-Ferrer J, Picado C. Comparative study of the effects of different gluco-'corticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 1995; 50: 270-274.
6. Paolieri F, Battifora M, Riccio AM, et al. Inhibition of adhesion molecules by budesonide on a human epithelial cell line (lung carcinoma). Allergy 1997; 52: 935-943.
7. Wheller SK, Perretti M. Dexamethasone inhibits cytokine-induced intercellular adhesion molecule-1 up-regulation on endothelial cell lines. Eur J Pharmacol 1997; 331: 65-71.
8. John M, Hirst SJ, Jose PJ, et al. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 1997; 158: 1841-1847.
9. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/1L-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992; 79: 45-51.
10. Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152: 838-860.
11. Eda R, Sugiyama H, Hopp RJ, Okada C, Bewtra AK, Townley RG. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation. Int Arch Allergy Immunol 1993; 102: 391-398.
12. Mita H, Shida T. Anti-allergic activity of formoterol, a new beta-adrenoceptor stimulant, and salbutamol in human leukocytes and human lung tissue. Allergy 1983; 38: 547-552.
13. Palmqvist M, Balder B, Lowhagen O, Melander B, Svedmyr N, Wahlander L. Late asthmatic reaction decreased after pretreatment with salbutamol and formoterol, a new long-acting beta 2-agonist. J Allergy Clin Immunol 1992; 89: 844-849.
14. Wong BJ, Dolovich J, Ramsdale EH, et al. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 146: 1156-1160.
15. Wallin A, Sandstrom T, Soderberg M, et al. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1999; 159: 79-85.
16. Sugiyama H, Okada C, Bewtra AK, Hopp RJ, Townley RG. The effect of formoterol on the late asthmatic phenomena in guinea pigs. J Allergy Clin Immunol 1992; 89: 858-866.
17. Bowden JJ, Sulakvelidze I, McDonald DM. Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol. J Appl Physiol 1994; 77: 397-405.
18. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large end small airways of asthmatics. Eur Respir J 1997; 10: 292-300.
19. Hamid Q, Song YL, Kotsimbos TC, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100: 44-51.
20. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992; 79: 45-51.
21. Noso N, Sticherling M, Bartels J, Mallet AI, Christophers E, Schröder JM. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts. J Immunol 1996; 156: 1946-1953.
22. Schlaak JF, Schwarting A, Knolle P, Meyer zum Buschenfelde KH, Mayet W. Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts. Ann Rheum Dis 1995; 54: 560-565.
23. Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF. Interferon-γ and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts. Eur Respir J 1999; 14: 759-766.
24. Morzycki W, Issekutz AC. Tumour necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism. Immunology 1991; 74: 107-113.
25. Tessier PA, Cattaruzzi P, McColl SR. Inhibition of lymphocyte adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arthritis Rheum 1996; 39: 226-234.
26. Takafuji S, Shoji S, Ito K, Yamamoto K, Nakagawa T. Eosinophil degranulation in the presence of lung fibroblasts. Int Arch Allergy Immunol 1998; 117: 52-54.
27. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-association antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994; 179: 1145-1154.
28. Piela Smith TH, Broketa G, Hand A, Korn JH. Regulation of ICAM-1 expression and function in human dermal fibroblasts by 1L-4. J Immunol 1992; 148: 1375-1381.
29. Van den Bosch JM, Westermann CJ, Aumann J, Edsbacker S, Tonnesson M, Selroos O. Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos 1993; 14: 455-459.
30. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role oftranscriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
31. Van der Saag PT, Caldenhoven E, Van de Stolpe A. Molecular mechanisms of steroid action: a novel type of cross-talk between glucocorticoids and NF-kappa B transcription factors. Eur Respir J Suppl. 1996; 22: 146s-153s.
32. Van de Stolpe A, Van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13-33.
33. Ahmad M, Theofanidis P, Medford RM. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-a. J Biol Chem 1998; 273: 4616-4621.
34. Lockyer JM, Colladay JS, Alperin-Lea WL, Hammond T, Buda AJ. Inhibition of nuclear factor-kappaB-mediated adhesion molecule expression in human endothelial cells. Circ Res 1998; 82: 314-320.
35. Bloemen PGM, van den Tweel MC, Henricks PAJ, et al. Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 1997; 272: L580-L587.
36. Kilfeather SA, Collins D, McCormack P, Cotter T, O'Malley K. The effect of in vitro aging on human lung fibroblast beta-adrenergic receptor density, coupling and response. Mech Ageing Dev 1992; 63: 247-256.
37. 2-adrenoceptor agonist. J Asthma 1998; 35: 401-408.
38. Masquilier D, Sassone CP. Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J Biol Chem 1992; 267: 22460-22466.
39. Braun M, Pietsch P, Zepp A, Schrör K, Baumann G, Felix SB. Regulation of tumour necrosis factor-α and interleukin-1β induced adhesion molecule expression in human vascular smooth muscle cells by cAMP. Arterioscler Thromb Vasc Biol 1997; 17: 2568-2575.
40. Campestrini J, Lecaillon JB, Godbillon J. Automated and sensitive method for the determination of formoterol in human plasma by high-performance liquid chromatography and electrochemical detection. J Chromatogr B Biomed Sci Appl 1997; 704: 221-229.
41. Penuelas I, Encio IJ, Lopez-Moratalla N, Santiago E. cAMP activates transcription of the human glucocorticoid receptor gene promoter. J Steroid Biochem Mol Biol 1998: 67: 89-94.
42. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999; 274: 1005-1010.